American National Bank Decreased Johnson & Johnson Com (JNJ) Position By $661,135, Evertz Technologies Limited (TSE:ET) Had 3 Analysts Last Week

May 19, 2017 - By Hazel Jackson

American National Bank decreased Johnson & Johnson Com (JNJ) stake by 8.08% reported in 2016Q4 SEC filing. American National Bank sold 5,749 shares as Johnson & Johnson Com (JNJ)’s stock 0.00%. The American National Bank holds 65,397 shares with $7.53 million value, down from 71,146 last quarter. Johnson & Johnson Com now has $341.91 billion valuation. The stock declined 0.27% or $0.35 reaching $126.62 per share. About 4.83M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 3 analysts covering Evertz Technologies Limited (TSE:ET), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evertz Technologies Limited had 13 analyst reports since September 9, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets on Monday, June 6 with “Outperform”. RBC Capital Markets maintained it with “Outperform” rating and $22 target in Wednesday, September 7 report. The firm earned “Outperform” rating on Thursday, March 2 by BMO Capital Markets. See Evertz Technologies Limited (TSE:ET) latest ratings:

02/03/2017 Broker: BMO Capital Markets Rating: Outperform New Target: $19.00 Maintain
02/03/2017 Broker: Canaccord Genuity Rating: Old Target: $20.00 New Target: $19.00 Target Down
02/03/2017 Broker: Raymond James Rating: Outperform Old Target: $19.00 New Target: $18.00 Target Down
02/03/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $22.00 New Target: $21.00 Target Down
02/12/2016 Broker: RBC Capital Markets Rating: Outperform Old Target: $22.00 New Target: $23.00 Target Up

About 5,440 shares traded. Evertz Technologies Limited (TSE:ET) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Evertz Technologies Limited is an equipment well-known provider to the television broadcast telecommunications and media industries. The company has market cap of $1.27 billion. The Firm designs, makes and markets video and audio infrastructure equipment for the production, post-production and transmission of television content. It has a 22.16 P/E ratio. The Company’s solutions are purchased by content creators, broadcasters, specialty channels and television service providers to support their multi-channel digital and high definition television and high bandwidth low latency Internet Protocol (IP) network environments, and by telecommunications and new-media companies.

Since February 1, 2017, it had 0 buys, and 5 sales for $14.98 million activity. 22,000 shares were sold by Stoffels Paulus, worth $2.58 million. Another trade for 21,735 shares valued at $2.45M was sold by Ullmann Michael H. Shares for $6.18 million were sold by Duato Joaquin on Friday, March 3. 14,543 shares were sold by Kapusta Ronald A, worth $1.78M. Pruden Gary J sold $1.99M worth of Johnson & Johnson (NYSE:JNJ) on Tuesday, February 28.

Among 15 analysts covering Johnson & Johnson (NYSE:JNJ), 7 have Buy rating, 1 Sell and 7 Hold. Therefore 47% are positive. Johnson & Johnson had 42 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Strong-Buy” rating by Vetr on Monday, August 31. S&P Research maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, October 14. S&P Research has “Buy” rating and $120 target. The firm earned “Hold” rating on Tuesday, June 14 by Jefferies. As per Thursday, January 26, the company rating was downgraded by Wells Fargo. The rating was maintained by Argus Research on Wednesday, April 20 with “Buy”. The firm has “Hold” rating given on Thursday, August 4 by Jefferies. Cowen & Co maintained the stock with “Outperform” rating in Tuesday, August 25 report. The stock has “Buy” rating by Deutsche Bank on Tuesday, September 29. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, July 20. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by UBS on Wednesday, October 19.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.12, from 0.82 in 2016Q3. It is positive, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. 69,657 were accumulated by Vantage Investment Lc. Sunbelt Securities invested 0% of its portfolio in Johnson & Johnson (NYSE:JNJ). Badgley Phelps And Bell accumulated 1.17% or 116,914 shares. Carroll Assoc Inc reported 1.49% in Johnson & Johnson (NYSE:JNJ). Lowe Brockenbrough And holds 2.17% or 112,766 shares in its portfolio. Compass Capital Management Inc owns 181,081 shares for 3.89% of their portfolio. Wesbanco Bank accumulated 289,437 shares. Axa holds 2.54 million shares or 1.37% of its portfolio. Aviance Capital Prtn Ltd Liability Com has 0.84% invested in Johnson & Johnson (NYSE:JNJ). Wms Prtnrs Ltd Com has invested 3.04% in Johnson & Johnson (NYSE:JNJ). Conning owns 342,048 shares for 1.57% of their portfolio. Fayez Sarofim And reported 2.29 million shares. Azimuth Capital Mgmt Limited Liability Company, a Michigan-based fund reported 221,450 shares. Northstar Ltd Liability Corp invested in 2.45% or 95,190 shares. Karpas Strategies Limited Liability Corp holds 138,970 shares or 7.55% of its portfolio.

American National Bank increased Schlumberger Ltd Com (NYSE:SLB) stake by 15,480 shares to 16,623 valued at $1.40M in 2016Q4. It also upped Celanese Corp Series A (NYSE:CE) stake by 4,485 shares and now owns 58,659 shares. Coresite Realty Corp (NYSE:COR) was raised too.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 18. They expect $1.78 earnings per share, up 2.30% or $0.04 from last year’s $1.74 per share. JNJ’s profit will be $4.81 billion for 17.79 P/E if the $1.78 EPS becomes a reality. After $1.83 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.73% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts